Biotechnology (59) | Agency Agreements (59)

Browse by Company

AbbVie Inc. (2)
ADiTx Therapeutics, Inc. (1)
Altimmune, Inc. (1)
ATOSSA GENETICS INC (3)
Benitec Biopharma Inc. (1)
BioCardia, Inc. (2)
BIOCEPT INC (2)
CAPRICOR THERAPEUTICS, INC. (1)
Cellectar Biosciences, Inc. (1)
Chardan Healthcare Acquisition Corp. (1)
CLEVELAND BIOLABS INC (1)
CTD HOLDINGS INC (1)
Cyclacel Pharmaceuticals, Inc. (2)
DelMar Pharmaceuticals, Inc. (3)
Emerald Bioscience, Inc. (1)
Genprex, Inc. (4)
GX Acquisition Corp. (1)
InMed Pharmaceuticals Inc. (1)
Inmune Bio, Inc. (1)
LEXICON PHARMACEUTICALS, INC. (1)
LONGEVERON LLC (1)
MARIZYME INC (2)
MATEON THERAPEUTICS INC (2)
Moleculin Biotech, Inc. (1)
NEUROTROPE BIOSCIENCE, INC. (1)
ONCOSEC MEDICAL Inc (1)
Petra Acquisition Inc. (1)
Phio Pharmaceuticals Corp. (1)
PLURISTEM THERAPEUTICS INC (1)
Propanc Biopharma, Inc. (1)
REXAHN PHARMACEUTICALS, INC. (2)
Rezolute, Inc. (1)
RITTER PHARMACEUTICALS INC (4)
Scholar Rock Holding Corp (1)
Seres Therapeutics, Inc. (1)
Tonix Pharmaceuticals Holding Corp. (4)
VITAL THERAPIES INC (1)
YIELD10 BIOSCIENCE, INC. (1)
ZIOPHARM ONCOLOGY INC (1)

Recent Contracts

Form of Warrant Agency Agreement, by and between Benitec Biopharma Inc. and Computershare Trust Company, N.A., as warrant agent (Benitec Biopharma Inc., Filed With SEC on August 10, 2022)
Form of Placement Agency Agreement (Petra Acquisition Inc., Filed With SEC on July 13, 2022)
Placement Agency Agreement, dated June 29, 2022, by and between Seres Therapeutics, Inc. and J.P. Morgan Securities LLC (Seres Therapeutics, Inc., Filed With SEC on June 30, 2022)
Placement Agency Agreement by and among the Registrant, J.P. Morgan Securities LLC and Piper Sandler & Co. dated June 17, 2022 (Scholar Rock Holding Corp, Filed With SEC on June 21, 2022)
Placement Agency Agreement, dated as of May 18, 2022, among Celularity Inc. and the placement agent party thereto (GX Acquisition Corp., Filed With SEC on May 20, 2022)
Placement Agency Agreement, dated as of May 1, 2022, by and between the Company and Jefferies LLC (Rezolute, Inc., Filed With SEC on May 4, 2022)
Placement Agency Agreement, dated April 12, 2022, by and between Kintara Therapeutics, Inc. and A.G.P./Alliance Global Partners (DelMar Pharmaceuticals, Inc., Filed With SEC on April 13, 2022)
Placement Agency Agreement, dated February 6, 2021, by and between Statera Biopharma, Inc. and EF Hutton, a division of Benchmark Investments, LLC (CLEVELAND BIOLABS INC, Filed With SEC on February 7, 2022)
Placement Agency Agreement between Marizyme, Inc. and Univest Securities, LLC, dated December 10, 2021 (MARIZYME INC, Filed With SEC on December 27, 2021)
Placement Agency Agreement dated November 30, 2021 (LONGEVERON LLC, Filed With SEC on December 3, 2021)